Adaptimmune Therapeutics plc (ADAP) has 12 identified peers for comparison in the Healthcare sector. Peers include ACET, AFMD, AGIO, APTO, BDTX, CRVS and others.
ADAP has a market capitalization of $75.16M, compared to an average peer market cap of $1.1B. ADAP is notably smaller than its average peer.
